文献

J-GLOBAL ID：202202221247159358   整理番号：22A0216804

双極性障害におけるin vivo海馬サブフィールド容積-Meta分析双極性障害ワーキンググループによる神経イメージング遺伝学強化からのメガ解析【JST・京大機械翻訳】

In vivo hippocampal subfield volumes in bipolar disorder-A mega-analysis from The Enhancing Neuro Imaging Genetics through Meta-Analysis Bipolar Disorder Working Group

著者 (120件)： Haukvik Unn K. (Department of Adult Mental Health, Institute of Clinical Medicine, University of Oslo, Oslo, Norway) ,  Haukvik Unn K. (Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway) ,  Gurholt Tiril P. (Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway) ,  Gurholt Tiril P. (Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway) ,  Gurholt Tiril P. (Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway) ,  Nerland Stener (Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway) ,  Nerland Stener (Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway) ,  Elvsashagen Torbjorn (Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway) ,  Elvsashagen Torbjorn (Department of Neurology, Oslo University Hospital, Oslo, Norway) ,  Elvsashagen Torbjorn (Institute of Clinical Medicine, University of Oslo, Oslo, Norway) ,  Akudjedu Theophilus N. (Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland) ,  Akudjedu Theophilus N. (Institute of Medical Imaging & Visualisation, Faculty of Health & Social Sciences, Bournemouth University, Bournemouth, UK) ,  Alda Martin (Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada) ,  Alda Martin (National Institute of Mental Health, Klecany, Czech Republic) ,  Alnaes Dag (Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway) ,  Alnaes Dag (Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway) ,  Alonso-Lana Silvia (FIDMAG Germanes Hospitalaries Research Foundation, CIBERSAM, Barcelona, Spain) ,  Bauer Jochen (Institute of Clinical Radiology, University of Muenster, Muenster, Germany) ,  Baune Bernhard T. (Department of Psychiatry, University of Muenster, Muenster, Germany) ,  Baune Bernhard T. (Department of Psychiatry, Melbourne Medical School, The University of Melbourne, Melbourne, Australia) ,  Baune Bernhard T. (The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Australia) ,  Benedetti Francesco (Psychiatry and Clinical Psychobiology, Scientific Institute Ospedale San Raffaele, Milan, Italy) ,  Benedetti Francesco (University Vita-Salute San Raffaele, Milan, Italy) ,  Berk Michael (Deakin University, IMPACT, the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Victoria, Australia) ,  Berk Michael (Orygen, The National Centre of Excellence in Youth Mental Health and Centre for Youth Mental Health, the Department of Psychiatry and the Florey Institute for Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia) ,  Bettella Francesco (Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway) ,  Boen Erlend (Psychosomatic and CL Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway) ,  Bonnin Caterina M. (Barcelona Bipolar Disorders and Depressive Unit, Hospital Clinic, Institute of Neurosciences, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain) ,  Brambilla Paolo (Department of Neurosciences and Mental Health, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy) ,  Brambilla Paolo (Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy) ,  Canales-Rodriguez Erick J. (FIDMAG Germanes Hospitalaries Research Foundation, CIBERSAM, Barcelona, Spain) ,  Cannon Dara M. (Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland) ,  Caseras Xavier (MRC Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK) ,  Dandash Orwa (Brain, Mind and Society Research Hub, Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia) ,  Dandash Orwa (Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Melbourne, Victoria, Australia) ,  Dannlowski Udo (Department of Psychiatry, University of Muenster, Muenster, Germany) ,  Delvecchio Giuseppe (Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy) ,  Diaz-Zuluaga Ana M. (Research Group in Psychiatry, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellin, Antioquia, Colombia) ,  van Erp Theo G. M. (Clinical Translational Neuroscience Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, California, USA) ,  van Erp Theo G. M. (Center for the Neurobiology of Learning, University of California Irvine and Memory, Irvine, California, USA) ,  Fatjo-Vilas Mar (FIDMAG Germanes Hospitalaries Research Foundation, CIBERSAM, Barcelona, Spain) ,  Foley Sonya F. (Cardiff University Brain Research Imaging Centre (CUBRIC), Cardiff University, Cardiff, UK) ,  Forster Katharina (Department of Psychiatry, University of Muenster, Muenster, Germany) ,  Fullerton Janice M. (Neuroscience Research Australia, Randwick, New South Wales, Australia) ,  Fullerton Janice M. (School of Medical Sciences, The University of New South Wales, Sydney, New South Wales, Australia) ,  Goikolea Jose M. (Barcelona Bipolar Disorders and Depressive Unit, Hospital Clinic, Institute of Neurosciences, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain) ,  Grotegerd Dominik (Department of Psychiatry, University of Muenster, Muenster, Germany) ,  Gruber Oliver (Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University Hospital, Heidelberg, Germany) ,  Haarman Bartholomeus C. M. (Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands) ,  Haatveit Beathe (Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway) ,  Haatveit Beathe (Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway) ,  Hajek Tomas (Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada) ,  Hajek Tomas (National Institute of Mental Health, Klecany, Czech Republic) ,  Hallahan Brian (Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland) ,  Harris Mathew (Division of Psychiatry, University of Edinburgh, Edinburgh, UK) ,  Hawkins Emma L. (Division of Psychiatry, University of Edinburgh, Edinburgh, UK) ,  Howells Fleur M. (Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, Western Cape, South Africa) ,  Howells Fleur M. (Neuroscience Institute, University of Cape Town, Cape Town, Western Cape, South Africa) ,  Huelsmann Carina (Department of Psychiatry, University of Muenster, Muenster, Germany) ,  Jahanshad Neda (Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, California, USA) ,  Jorgensen Kjetil N. (Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway) ,  Jorgensen Kjetil N. (Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway) ,  Kircher Tilo (Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany) ,  Kircher Tilo (Center for Mind, Brain and Behavior (CMBB), Marburg, Germany) ,  Kraemer Bernd (Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University Hospital, Heidelberg, Germany) ,  Krug Axel (Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany) ,  Krug Axel (Center for Mind, Brain and Behavior (CMBB), Marburg, Germany) ,  Krug Axel (Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany) ,  Kuplicki Rayus (Laureate Institute for Brain Research, Tulsa, Oklahoma, USA) ,  Lagerberg Trine V. (Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway) ,  Lancaster Thomas M. (Cardiff University Brain Research Imaging Centre (CUBRIC), Cardiff University, Cardiff, UK) ,  Lancaster Thomas M. (School of Psychology, Bath University, Bath, UK) ,  Lenroot Rhoshel K. (Neuroscience Research Australia, Randwick, New South Wales, Australia) ,  Lenroot Rhoshel K. (School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia) ,  Lenroot Rhoshel K. (University of New Mexico, Albuquerque, New Mexico, USA) ,  Lonning Vera (Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway) ,  Lonning Vera (Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway) ,  Lopez-Jaramillo Carlos (Research Group in Psychiatry, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellin, Antioquia, Colombia) ,  Lopez-Jaramillo Carlos (Mood Disorders Program, Hospital Universitario San Vicente Fundacion, Medellin, Antioquia, Colombia) ,  Malt Ulrik F. (Institute of Clinical Medicine, University of Oslo, Oslo, Norway) ,  McDonald Colm (Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland) ,  McIntosh Andrew M. (Division of Psychiatry, University of Edinburgh, Edinburgh, UK) ,  McPhilemy Genevieve (Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland) ,  van der Meer Dennis (Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway) ,  van der Meer Dennis (School of Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands) ,  Melle Ingrid (Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway) ,  Melle Ingrid (Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway) ,  Melloni Elisa M. T. (Psychiatry and Clinical Psychobiology, Scientific Institute Ospedale San Raffaele, Milan, Italy) ,  Melloni Elisa M. T. (University Vita-Salute San Raffaele, Milan, Italy) ,  Mitchell Philip B. (School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia) ,  Mitchell Philip B. (Black Dog Institute, Sydney, New South Wales, Australia) ,  Nabulsi Leila (Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland) ,  Nenadic Igor (Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany) ,  Nenadic Igor (Center for Mind, Brain and Behavior (CMBB), Marburg, Germany) ,  Oertel Viola (Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany) ,  Oldani Lucio (Department of Neurosciences and Mental Health, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy) ,  Opel Nils (Department of Psychiatry, University of Muenster, Muenster, Germany) ,  Otaduy Maria C. G. (LIM44, Department of Radiology and Oncology, University of Sao Paulo, Sao Paulo, Brazil) ,  Overs Bronwyn J. (Neuroscience Research Australia, Randwick, New South Wales, Australia) ,  Pineda-Zapata Julian A. (Research Group in Psychiatry, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellin, Antioquia, Colombia) ,  Pineda-Zapata Julian A. (Research Group, Instituto de Alta Tecnologia Medica, Medellin, Antioquia, Colombia) ,  Pomarol-Clotet Edith (FIDMAG Germanes Hospitalaries Research Foundation, CIBERSAM, Barcelona, Spain) ,  Radua Joaquim (Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS), CIBERSAM, Barcelona, Spain) ,  Radua Joaquim (Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK) ,  Radua Joaquim (Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden) ,  Rauer Lisa (Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University Hospital, Heidelberg, Germany) ,  Redlich Ronny (Department of Psychiatry, University of Muenster, Muenster, Germany) ,  Repple Jonathan (Department of Psychiatry, University of Muenster, Muenster, Germany) ,  Rive Maria M. (Psychiatry, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands) ,  Roberts Gloria (School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia) ,  Roberts Gloria (Black Dog Institute, Sydney, New South Wales, Australia) ,  Ruhe Henricus G. (Psychiatry, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands) ,  Ruhe Henricus G. (Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, The Netherlands) ,  Ruhe Henricus G. (Department of Psychiatry, Radboudumc, Nijmegen, The Netherlands) ,  Salminen Lauren E. (Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, California, USA) ,  Salvador Raymond (FIDMAG Germanes Hospitalaries Research Foundation, CIBERSAM, Barcelona, Spain) ,  Sarro Salvador (FIDMAG Germanes Hospitalaries Research Foundation, CIBERSAM, Barcelona, Spain) ,  Savitz Jonathan (Laureate Institute for Brain Research, Tulsa, Oklahoma, USA) ,  Savitz Jonathan (Oxley College of Health Sciences, The University of Tulsa, Tulsa, Oklahoma, USA) ,  Schene Aart H. (Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, The Netherlands)
資料名： Human Brain Mapping  (Human Brain Mapping)
巻： 43  号： 1  ページ： 385-398  発行年： 2022年 
JST資料番号： W2600A  ISSN： 1065-9471  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 海馬は,双極性障害(BD)の病態生理に差別的に関与する可能性がある解剖学的および機能的に異なるサブフィールドから成る。ここでは,Meta-Analysis Bipolar Disorder Disork GroupによるEnhancing NeuroImageing Geneticsを,BDにおける海馬サブフィールド容積測定により検討した。世界中の23地点からの4,698個体(BD=1,472,健常対照者[HC]=3,226)からのT1強調磁気共鳴画像スキャンをFreeSurferにより処理した。BDとHCの間の海馬サブフィールド容積の違いを調査するために,線形混合効果モデルとメガ分析を用い,続いて臨床的特徴と投薬使用を分析した。BDは,HCと比較して,海馬全体(Cohen’s d=-0.20),cornu Ammunis(CA)1(d=-0.18),CA2/3(d=-0.11),CA4(d=-0.19),分子層(d=-0.21),歯状回(d=-0.12),海馬尾部(d=-0.10),小丘(d=-0.15),海馬尾部(d=-0.18),海馬扁桃体転移領域(d=-0.17)の有意に小さい体積を示した。リチウム使用者はHCと比較して体積差を示さなかったが,非使用者はそうであった。抗精神病または抗てんかん薬使用は,より小さな容積と関連していた。今日まで,BDにおける海馬サブフィールドのこの最大研究において,著者らは研究した12のサブフィールドのうち9つで広範な減少を示した。関連は薬物使用により調節され,特にリチウム使用者とHCの間の差異の欠如はBDにおけるリチウムの可能性のある保護的役割を支持した。Copyright 2022 Wiley Publishing Japan K.K. All rights reserved. Translated from English into Japanese by JST.【JST・京大機械翻訳】

シソーラス用語： リチウム ,  体積測定 ,  抗痙攣薬 ,  精神病 ,  *双極性障害 ,  *海馬 ,  薬物療法 ,  線形性 ,  扁桃核 ,  解剖学 ,  NMRイメージング ,  歯状回
準シソーラス用語： 差別 ,  *ニューロイメージング ,  臨床的特徴 , 【Automatic Indexing@JST】

著者キーワード (6件)： 双極性障害サブタイプ ,  海馬 ,  大規模スケール ,  リチウム ,  精神病 ,  構造的脳MRI

分類 (3件)： 中枢神経系  (EJ12030F) ,  神経の基礎医学  (GN01020W) ,  神経系の診断  (GN02000H)

タイトルに関連する用語 (11件)： 双極性障害 ,  海馬 ,  サブ ,  フィールド ,  容積 ,  分析 ,  ワーキンググループ ,  神経イメージング ,  遺伝学 ,  強化 ,  解析